Williams AJK - Search Results

1

A novel LIPS assay for insulin autoantibodies.

Liberati D, Wyatt RC, Brigatti C, Marzinotto I, Ferrari M, Bazzigaluppi E, Bosi E, Gillard BT, Gillespie KM, Gorus F, Weets I, Balti E, Piemonti L, Achenbach P, Williams AJK, Lampasona V. Liberati D, et al. Among authors: williams ajk. Acta Diabetol. 2018 Mar;55(3):263-270. doi: 10.1007/s00592-017-1082-y. Epub 2018 Jan 5. Acta Diabetol. 2018. PMID: 29305766

2

A novel micro-assay for insulin autoantibodies.

Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA. Williams AJ, et al. J Autoimmun. 1997 Oct;10(5):473-8. doi: 10.1006/jaut.1997.0154. J Autoimmun. 1997. PMID: 9376075

3

Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetes.

Williams AJ, Bingley PJ, Chance RE, Gale EA. Williams AJ, et al. J Autoimmun. 1999 Nov;13(3):357-63. doi: 10.1006/jaut.1999.0329. J Autoimmun. 1999. PMID: 10550223

4

Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

Gardner SG, Gale EA, Williams AJ, Gillespie KM, Lawrence KE, Bottazzo GF, Bingley PJ. Gardner SG, et al. Diabetes Care. 1999 Dec;22(12):2049-54. doi: 10.2337/diacare.22.12.2049. Diabetes Care. 1999. PMID: 10587841

5

The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence.

Williams AJ, Norcross AJ, Dix RJ, Gillespie KM, Gale EA, Bingley PJ. Williams AJ, et al. Diabetologia. 2003 Oct;46(10):1354-6. doi: 10.1007/s00125-003-1197-2. Epub 2003 Sep 9. Diabetologia. 2003. PMID: 13680123

6

Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.

Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, Bonifacio E, Ziegler AG. Achenbach P, et al. Diabetes. 2004 Feb;53(2):384-92. doi: 10.2337/diabetes.53.2.384. Diabetes. 2004. PMID: 14747289

7

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.

Gale EA, Bingley PJ, Emmett CL, Collier T; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Gale EA, et al. Lancet. 2004 Mar 20;363(9413):925-31. doi: 10.1016/S0140-6736(04)15786-3. Lancet. 2004. PMID: 15043959 Clinical Trial.

8

Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives.

Achenbach P, Warncke K, Reiter J, Williams AJ, Ziegler AG, Bingley PJ, Bonifacio E. Achenbach P, et al. Diabetologia. 2006 Dec;49(12):2969-76. doi: 10.1007/s00125-006-0451-9. Epub 2006 Sep 26. Diabetologia. 2006. PMID: 17019596

9

Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program.

Achenbach P, Schlosser M, Williams AJ, Yu L, Mueller PW, Bingley PJ, Bonifacio E. Achenbach P, et al. Clin Immunol. 2007 Jan;122(1):85-90. doi: 10.1016/j.clim.2006.09.004. Epub 2006 Oct 23. Clin Immunol. 2007. PMID: 17059894

10

Islet autoimmunity in children with Down's syndrome.

Gillespie KM, Dix RJ, Williams AJ, Newton R, Robinson ZF, Bingley PJ, Gale EA, Shield JP. Gillespie KM, et al. Diabetes. 2006 Nov;55(11):3185-8. doi: 10.2337/db06-0856. Diabetes. 2006. PMID: 17065360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page